Endemic Fungal Infections in Inflammatory Bowel Disease Associated with Anti-TNF Antibody Therapy

Evidence from Genetics for a Role of Autophagy and Innate Immunity in IBD Pathogenesis

(2012) Miles Parkes   DIGESTIVE DISEASES

Epigenetics: Concepts and relevance to IBD pathogenesis

(2012) Melania Scarpa et al.   INFLAMMATORY BOWEL DISEASES

Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

(2012) Sotirios Tsiodras et al.   MAYO CLINIC PROCEEDINGS

Reactivation of Coccidioidomycosis Despite Antifungal Prophylaxis in Solid Organ Transplant Recipients

(2011) David W. Keckich et al.   TRANSPLANTATION

Coccidioidomycosis and Lung Transplantation

(2011) Holenarasipur R. Vikram et al.   TRANSPLANTATION

Review article: explaining risks of inflammatory bowel disease therapy to patients

(2010) C. A. Siegel   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Coccidioidomycosis in Liver Transplant Recipients in an Endemic Area

(2010) D. Vucicevic et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Safety and Efficacy of the Tumor Necrosis Factor Antagonists

(2010) F. Bachmann et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections

(2009) S. SCHNEEWEISS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy

(2009) Chadi A. Hage et al.   CLINICAL INFECTIOUS DISEASES

Blastomycosis: New Insights into Diagnosis, Prevention, and Treatment

(2009) James A. McKinnell et al.   CLINICS IN CHEST MEDICINE

Safety Profile of IBD Therapeutics: Infectious Risks

(2009) Waqqas Afif et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Adalimumab safety in global clinical trials of patients with Crohnʼs disease

(2009) Jean-Frédéric Colombel et al.   INFLAMMATORY BOWEL DISEASES

Antigen and Antibody Testing for the Diagnosis of Blastomycosis in Dogs

(2009) D. Spector et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Safety Profile of IBD Therapeutics: Infectious Risks

(2009) Waqqas Afif et al.   MEDICAL CLINICS OF NORTH AMERICA

The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up

(2008) C. W. LEES et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mycobacterial and Other Serious Infections in Patients Receiving Anti–Tumor Necrosis Factor and Other Newly Approved Biologic Therapies: Case Finding through the Emerging Infections Network

(2008) Kevin L. Winthrop et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America

(2008) Stanley W. Chapman et al.   CLINICAL INFECTIOUS DISEASES

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

(2008) H Fidder et al.   GUT

Oral histoplasmosis: An unusual presentation

(2008) Nagamani Narayana et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophagocytic syndrome in HIV infection

(2008) Marc De Lavaissière et al.   JOURNAL OF INFECTION

Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis

(2008) Barbara Segal et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS

Pulmonary Blastomycosis

(2008) Robert Bradsher   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Infliximab-induced disseminated histoplasmosis in a patient with Crohn's disease

(2008) Susan Galandiuk et al.   Nature clinical practice. Gastroenterology & hepatology